Company · CIK 0001628171 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Revolution Medicines, Inc. · RVMD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 6:00 pm EDT | Elizabeth M AndersonDirector | 10,143 | $193.04 | $1,958,016 | 4,333 | −70.1% | 10b5-1 |
| Sep 22, 2026 MForm 4 → | Sep 24, 6:00 pm EDT | Elizabeth M AndersonDirector | 5,070 | $1.12 | $5,678 | 14,476 | — | 10b5-1 |
| Sep 18, 2026 SForm 4 → | Sep 22, 6:00 pm EDT | Anthony ManciniSee Remarks | 1,764 | $196.94 | $347,402 | 40,352 | −4.19% | 10b5-1 |
| Sep 16, 2026 SForm 4 → | Sep 18, 6:06 pm EDT | Alan B. SandlerChief Development Officer | 341 | $199.24 | $67,941 | 52,868 | −0.64% | 10b5-1 |
| Sep 16, 2026 SForm 4 → | Sep 18, 6:05 pm EDT | Anthony ManciniSee Remarks | 1,774 | $199.24 | $353,449 | 42,116 | −4.04% | 10b5-1 |
| Sep 16, 2026 SForm 4 → | Sep 18, 6:04 pm EDT | Stephen Michael KelseySee Remarks | 5,569 | $199.24 | $1,109,554 | 286,307 | −1.91% | 10b5-1 |
| Sep 16, 2026 SForm 4 → | Sep 18, 6:03 pm EDT | Margaret A HornChief Operating Officer | 4,967 | $199.24 | $989,613 | 149,680 | −3.21% | 10b5-1 |
| Sep 16, 2026 SForm 4 → | Sep 18, 6:02 pm EDT | Mark A GoldsmithSee Remarks, Director | 13,988 | $199.24 | $2,786,938 | 253,342 | −5.23% | 10b5-1 |
| Sep 16, 2026 SForm 4 → | Sep 18, 6:01 pm EDT | Jeff CisliniSVP & General Counsel | 3,366 | $199.24 | $670,631 | 52,541 | −6.02% | 10b5-1 |
| Sep 16, 2026 SForm 4 → | Sep 18, 6:00 pm EDT | Jack AndersChief Financial Officer | 4,053 | $199.24 | $807,513 | 119,216 | −3.29% | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 15, 6:00 pm EDT | Stephen Michael KelseySee Remarks | 92,531 | $202.36 | $18,724,767 | 291,876 | −24.1% | 10b5-1 |
| Sep 11, 2026 MForm 4 → | Sep 15, 6:00 pm EDT | Stephen Michael KelseySee Remarks | 92,531 | $41.71 | $3,859,488 | 384,407 | — | 10b5-1 |
| Sep 10, 2026 SForm 4 → | Sep 14, 6:03 pm EDT | Anthony ManciniSee Remarks | 15,448 | $204.16 | $3,153,807 | 43,890 | −26.0% | 10b5-1 |
| Sep 10, 2026 MForm 4 → | Sep 14, 6:03 pm EDT | Anthony ManciniSee Remarks | 9,363 | $33.62 | $314,784 | 59,338 | — | 10b5-1 |
| Sep 8, 2026 SForm 4 → | Sep 10, 5:52 pm EDT | Lorence H. KimDirector | 17,090 | $209.82 | $3,585,837 | 0 | −100% | 10b5-1 |
| Aug 31, 2026 SForm 4 → | Sep 2, 4:30 pm EDT | Lorence H. KimDirector | 56,000 | $203.24 | $11,381,288 | 17,090 | −76.6% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 MForm 4 → | Sep 24, 6:00 pm EDT | Elizabeth M AndersonDirector | 5,070 | — | — | 1,095 | — | 10b5-1 |
| Sep 11, 2026 MForm 4 → | Sep 15, 6:00 pm EDT | Stephen Michael KelseySee Remarks | 92,531 | $41.71 | $3,859,488 | 88,069 | — | 10b5-1 |
| Sep 10, 2026 MForm 4 → | Sep 14, 6:03 pm EDT | Anthony ManciniSee Remarks | 9,363 | — | — | 96,746 | — | 10b5-1 |